Comments
Loading...

I-MAB Analyst Ratings

IMABNASDAQ
Logo brought to you by Benzinga Data
$0.8890
0.044.59%
At close: -
$0.8380
-0.05-5.74%
After Hours: 7:00 PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$25.00
Lowest Price Target1
$6.00
Consensus Price Target1
$12.25

I-MAB Analyst Ratings and Price Targets | NASDAQ:IMAB | Benzinga

I-MAB has a consensus price target of $12.25 based on the ratings of 4 analysts. The high is $25 issued by Cantor Fitzgerald on September 5, 2023. The low is $6 issued by Needham on April 12, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on November 15, 2024, September 17, 2024, and August 29, 2024, respectively. With an average price target of $8 between HC Wainwright & Co., there's an implied 854.65% upside for I-MAB from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Nov 24
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Needham
Piper Sandler
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for I-MAB

Buy NowGet Alert
11/15/2024Buy Now854.65%HC Wainwright & Co.
Andrew Fein58%
$8 → $8ReiteratesBuy → BuyGet Alert
09/17/2024Buy Now854.65%HC Wainwright & Co.
Andrew Fein58%
$8 → $8ReiteratesBuy → BuyGet Alert
08/29/2024Buy Now854.65%HC Wainwright & Co.
Andrew Fein58%
$8 → $8ReiteratesBuy → BuyGet Alert
04/12/2024Buy Now615.99%Needham
Gil Blum52%
$6 → $6ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now1093.32%Piper Sandler
Joseph Catanzaro42%
$15 → $10MaintainsOverweightGet Alert
03/18/2024Buy Now854.65%HC Wainwright & Co.
Andrew Fein58%
$18 → $8ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now615.99%Needham
Gil Blum52%
$8 → $6MaintainsBuyGet Alert
02/08/2024Buy Now854.65%Needham
Gil Blum52%
$23 → $8MaintainsBuyGet Alert
09/25/2023Buy Now2644.63%Needham
Gil Blum52%
$24 → $23MaintainsBuyGet Alert
09/05/2023Buy Now2883.29%Cantor Fitzgerald
Louise Chen59%
→ $25ReiteratesOverweight → OverweightGet Alert
08/18/2023Buy Now2883.29%Cantor Fitzgerald
Louise Chen59%
→ $25ReiteratesOverweight → OverweightGet Alert
08/18/2023Buy Now2047.97%HC Wainwright & Co.
Andrew Fein58%
$25 → $18MaintainsBuyGet Alert
08/18/2023Buy Now2763.96%Needham
Gil Blum52%
→ $24ReiteratesBuy → BuyGet Alert
06/05/2023Buy Now2763.96%Needham
Gil Blum52%
→ $24ReiteratesBuy → BuyGet Alert
04/19/2023Buy Now2763.96%Needham
Gil Blum52%
→ $24Reiterates → BuyGet Alert
04/03/2023Buy Now2763.96%Needham
Gil Blum52%
$33 → $24MaintainsBuyGet Alert
04/03/2023Buy Now2883.29%Piper Sandler
Joseph Catanzaro42%
$30 → $25MaintainsOverweightGet Alert
04/03/2023Buy Now2883.29%HC Wainwright & Co.
Andrew Fein58%
$45 → $25MaintainsBuyGet Alert
08/31/2022Buy Now5269.93%HC Wainwright & Co.
Andrew Fein58%
$70 → $45MaintainsBuyGet Alert
08/31/2022Buy Now3837.95%Needham
Gil Blum52%
$41 → $33MaintainsBuyGet Alert
08/30/2022Buy Now3479.95%Piper Sandler
Joseph Catanzaro42%
$35 → $30MaintainsOverweightGet Alert
08/17/2022Buy Now4792.6%Needham
Gil Blum52%
$72 → $41MaintainsBuyGet Alert
05/31/2022Buy Now8253.22%HC Wainwright & Co.
Andrew Fein58%
$80 → $70MaintainsBuyGet Alert
05/31/2022Buy Now8491.89%Needham
Gil Blum52%
$85 → $72MaintainsBuyGet Alert
03/30/2022Buy Now9446.54%HC Wainwright & Co.
Andrew Fein58%
$95 → $80MaintainsBuyGet Alert

FAQ

Q

What is the target price for I-MAB (IMAB) stock?

A

The latest price target for I-MAB (NASDAQ:IMAB) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $8.00 expecting IMAB to rise to within 12 months (a possible 854.65% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for I-MAB (IMAB)?

A

The latest analyst rating for I-MAB (NASDAQ:IMAB) was provided by HC Wainwright & Co., and I-MAB reiterated their buy rating.

Q

When was the last upgrade for I-MAB (IMAB)?

A

There is no last upgrade for I-MAB

Q

When was the last downgrade for I-MAB (IMAB)?

A

There is no last downgrade for I-MAB.

Q

When is the next analyst rating going to be posted or updated for I-MAB (IMAB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of I-MAB, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for I-MAB was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

Q

Is the Analyst Rating I-MAB (IMAB) correct?

A

While ratings are subjective and will change, the latest I-MAB (IMAB) rating was a reiterated with a price target of $8.00 to $8.00. The current price I-MAB (IMAB) is trading at is $0.84, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch